| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 3.70e-09 | 43 | 111 | 7 | GO:0005231 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 2.84e-08 | 17 | 111 | 5 | GO:0022848 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.85e-08 | 57 | 111 | 7 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.10e-08 | 60 | 111 | 7 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 7.23e-08 | 65 | 111 | 7 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 7.23e-08 | 65 | 111 | 7 | GO:0022824 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 8.60e-08 | 100 | 111 | 8 | GO:0030594 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 1.51e-07 | 23 | 111 | 5 | GO:0015464 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 1.97e-07 | 75 | 111 | 7 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.37e-07 | 77 | 111 | 7 | GO:0005230 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 6.22e-07 | 13 | 111 | 4 | GO:0042166 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.15e-06 | 140 | 111 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.24e-05 | 193 | 111 | 8 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.44e-05 | 197 | 111 | 8 | GO:0022834 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor | 2.67e-05 | 11 | 111 | 3 | GO:0016670 | |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 3.06e-05 | 2 | 111 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1D TPTE TRPM4 HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE LRRC8A | 5.04e-05 | 459 | 111 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | 1.04e-04 | 334 | 111 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.27e-04 | 343 | 111 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1D TPTE TRPM4 HTR3A HTR3E ATP13A2 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE HRH1 LRRC8A ATP1A2 | 1.28e-04 | 793 | 111 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | CACNA1D TPTE TRPM4 HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE LRRC8A | 1.65e-04 | 525 | 111 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1D TPTE TRPM4 HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE LRRC8A | 1.68e-04 | 526 | 111 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | serotonin-gated monoatomic cation channel activity | 3.03e-04 | 5 | 111 | 2 | GO:0022850 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1D TRPM4 HTR3A HTR3E ATP13A2 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE HRH1 ATP1A2 | 3.24e-04 | 664 | 111 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | serotonin receptor activity | 4.53e-04 | 6 | 111 | 2 | GO:0099589 | |
| GeneOntologyMolecularFunction | thiol oxidase activity | 4.53e-04 | 6 | 111 | 2 | GO:0016972 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.98e-04 | 441 | 111 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 1.07e-03 | 9 | 111 | 2 | GO:0032795 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 1.53e-03 | 41 | 111 | 3 | GO:0008227 | |
| GeneOntologyMolecularFunction | FAD binding | 1.88e-03 | 44 | 111 | 3 | GO:0071949 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 1.88e-03 | 94 | 111 | 4 | GO:0050660 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.95e-03 | 12 | 111 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1D TPTE TRPM4 HTR3A HTR3E ATP9B ATP13A2 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ABCG1 HRH1 LRRC8A ATP1A2 | 2.02e-03 | 1289 | 111 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1D TPTE TRPM4 HTR3A HTR3E ATP13A2 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ABCG1 HRH1 LRRC8A ATP1A2 | 2.24e-03 | 1180 | 111 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.67e-03 | 14 | 111 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | FLT3 HTR3A OPN3 FFAR2 HTR3E TAAR5 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 LIFR ADRA2A PTPRF HRH1 | 3.28e-03 | 1353 | 111 | 16 | GO:0004888 |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 4.40e-08 | 130 | 114 | 9 | GO:0060079 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 1.27e-07 | 147 | 114 | 9 | GO:0099565 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.64e-07 | 121 | 114 | 8 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 7.09e-07 | 180 | 114 | 9 | GO:0060078 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1D TPTE TRPM4 HTR3A ERO1A WWP1 HTR3E STEAP4 ATP13A2 RGS4 CHRNA3 CHRNB1 CHRNB2 ALG10B CHRND CHRNE ADRA2A ALG10 HRH1 LRRC8A ATP1A2 | 7.14e-07 | 1115 | 114 | 21 | GO:0034220 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | DMXL2 HTR3A HTR3E SLITRK3 USP46 KAT2A BTBD9 RGS4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A CNTNAP4 HRH1 SYT5 ATP1A2 | 7.95e-07 | 931 | 114 | 19 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | DMXL2 HTR3A HTR3E SLITRK3 USP46 KAT2A BTBD9 RGS4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A CNTNAP4 HRH1 SYT5 ATP1A2 | 7.95e-07 | 931 | 114 | 19 | GO:0007268 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | DMXL2 HTR3A HTR3E SLITRK3 USP46 KAT2A BTBD9 RGS4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A CNTNAP4 HRH1 SYT5 ATP1A2 | 9.03e-07 | 939 | 114 | 19 | GO:0099537 |
| GeneOntologyBiologicalProcess | synaptic signaling | DMXL2 HTR3A HTR3E SLITRK3 USP46 KAT2A BTBD9 RGS4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A CNTNAP4 HRH1 SYT5 ATP1A2 | 1.60e-06 | 976 | 114 | 19 | GO:0099536 |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 4.32e-06 | 44 | 114 | 5 | GO:0007271 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1D TPTE TRPM4 HTR3A ERO1A WWP1 HTR3E STEAP4 ATP13A2 RGS4 CHRNA3 CHRNB1 CHRNB2 ALG10B CHRND CHRNE ADORA1 ADRA2A ALG10 HRH1 LRRC8A ATP1A2 | 5.40e-06 | 1374 | 114 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 9.06e-06 | 51 | 114 | 5 | GO:0095500 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 1.10e-05 | 53 | 114 | 5 | GO:1905145 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1D TRPM4 HTR3A TMEM135 HTR3E RGS4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ATP1A2 | 1.32e-05 | 559 | 114 | 13 | GO:0042391 |
| GeneOntologyBiologicalProcess | positive regulation of early endosome to late endosome transport | 1.35e-05 | 9 | 114 | 3 | GO:2000643 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 1.44e-05 | 56 | 114 | 5 | GO:1905144 | |
| GeneOntologyBiologicalProcess | melanin metabolic process | 1.89e-05 | 29 | 114 | 4 | GO:0006582 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 1.92e-05 | 10 | 114 | 3 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 1.92e-05 | 10 | 114 | 3 | GO:1902966 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 2.63e-05 | 11 | 114 | 3 | GO:0035095 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 4.00e-05 | 69 | 114 | 5 | GO:0098926 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to endosome | 5.73e-05 | 14 | 114 | 3 | GO:1905668 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 6.86e-05 | 125 | 114 | 6 | GO:0051952 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to endosome | 7.13e-05 | 15 | 114 | 3 | GO:1905666 | |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA1D TRPM4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A ATP1A2 | 7.62e-05 | 400 | 114 | 10 | GO:0006936 |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle, non-REM sleep | 8.74e-05 | 16 | 114 | 3 | GO:0042748 | |
| GeneOntologyBiologicalProcess | protein localization to early endosome | 8.74e-05 | 16 | 114 | 3 | GO:1902946 | |
| GeneOntologyBiologicalProcess | synaptic transmission involved in micturition | 9.05e-05 | 3 | 114 | 2 | GO:0060084 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 1.10e-04 | 338 | 114 | 9 | GO:0042593 | |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 1.12e-04 | 339 | 114 | 9 | GO:0033500 | |
| GeneOntologyBiologicalProcess | amine transport | 1.14e-04 | 137 | 114 | 6 | GO:0015837 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 1.39e-04 | 142 | 114 | 6 | GO:0018958 | |
| GeneOntologyBiologicalProcess | regulation of early endosome to late endosome transport | 1.75e-04 | 20 | 114 | 3 | GO:2000641 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.06e-04 | 217 | 114 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1D TRPM4 RGS4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A ATP1A2 | 2.26e-04 | 547 | 114 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | respiratory system process | 2.43e-04 | 55 | 114 | 4 | GO:0003016 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 2.69e-04 | 23 | 114 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | positive regulation of peptide secretion | 2.74e-04 | 161 | 114 | 6 | GO:0002793 | |
| GeneOntologyBiologicalProcess | response to nicotine | 2.98e-04 | 58 | 114 | 4 | GO:0035094 | |
| GeneOntologyBiologicalProcess | melanin biosynthetic process | 3.90e-04 | 26 | 114 | 3 | GO:0042438 | |
| GeneOntologyBiologicalProcess | response to blue light | 4.48e-04 | 6 | 114 | 2 | GO:0009637 | |
| GeneOntologyBiologicalProcess | secondary metabolite biosynthetic process | 4.87e-04 | 28 | 114 | 3 | GO:0044550 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 5.19e-04 | 67 | 114 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | positive regulation of insulin secretion | 5.43e-04 | 120 | 114 | 5 | GO:0032024 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1D TRPM4 ERO1A STEAP4 ATP13A2 RGS4 CHRNB1 CHRNB2 ALG10B CHRND CHRNE ADORA1 ADRA2A ALG10 HRH1 ATP1A2 | 6.22e-04 | 1157 | 114 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | EZR TRPM4 RDX ATP13A2 MSN ADORA1 ADRA2A WASHC5 HRH1 LRRC8A ATP1A2 | 6.32e-04 | 618 | 114 | 11 | GO:0090066 |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | EZR TRPM4 FLT3 HTR3A HTR3E KAT2A PIAS2 RGS4 CHRNB2 MSN ADORA1 IFNW1 DHH HRH1 ATP1A2 | 6.56e-04 | 1048 | 114 | 15 | GO:0014070 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 7.34e-04 | 438 | 114 | 9 | GO:0032970 | |
| GeneOntologyBiologicalProcess | positive regulation of protein secretion | 7.37e-04 | 194 | 114 | 6 | GO:0050714 | |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 7.56e-04 | 74 | 114 | 4 | GO:0051932 | |
| GeneOntologyBiologicalProcess | protein localization to endosome | 7.95e-04 | 33 | 114 | 3 | GO:0036010 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle, sleep | 7.95e-04 | 33 | 114 | 3 | GO:0050802 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 7.96e-04 | 272 | 114 | 7 | GO:0006813 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | EZR TRPM4 HTR3A HTR3E RGS4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE PTPRF HRH1 | 9.31e-04 | 752 | 114 | 12 | GO:1901699 |
| GeneOntologyBiologicalProcess | adult behavior | 9.33e-04 | 203 | 114 | 6 | GO:0030534 | |
| GeneOntologyBiologicalProcess | regulation of peptide transport | 9.82e-04 | 282 | 114 | 7 | GO:0090087 | |
| GeneOntologyBiologicalProcess | regulation of peptide secretion | 9.82e-04 | 282 | 114 | 7 | GO:0002791 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | EZR CACNA1D TRPM4 HTR3A FFAR2 HTR3E NOX4 LY96 RGS4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE MSN ABCG1 ADRA2A PTPRF | 9.86e-04 | 1450 | 114 | 18 | GO:1901701 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.03e-03 | 36 | 114 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle process | 1.03e-03 | 36 | 114 | 3 | GO:0022410 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 1.03e-03 | 36 | 114 | 3 | GO:0007274 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1D TRPM4 DMXL2 ERO1B ERO1A STEAP4 NOX4 ATP13A2 ADORA1 ABCG1 ADRA2A LRRC8A ATP1A2 AIM2 | 1.03e-03 | 981 | 114 | 14 | GO:0019725 |
| GeneOntologyBiologicalProcess | protein maturation by protein folding | 1.06e-03 | 9 | 114 | 2 | GO:0022417 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | USP46 KAT2A BTBD9 RGS4 CHRNA3 CHRNB2 ADORA1 ADRA2A CNTNAP4 HRH1 ATP1A2 | 1.12e-03 | 663 | 114 | 11 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | USP46 KAT2A BTBD9 RGS4 CHRNA3 CHRNB2 ADORA1 ADRA2A CNTNAP4 HRH1 ATP1A2 | 1.13e-03 | 664 | 114 | 11 | GO:0099177 |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 1.20e-03 | 38 | 114 | 3 | GO:0050951 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 3.58e-08 | 18 | 114 | 5 | GO:0005892 | |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1D HTR3A HTR3E SLITRK3 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A PTPRF MPP4 CNTNAP4 | 3.56e-06 | 583 | 114 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1D TRPM4 CATSPERE HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE LRRC8A | 7.12e-06 | 378 | 114 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | postsynaptic membrane | HTR3A HTR3E SLITRK3 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A PTPRF | 1.36e-05 | 405 | 114 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.46e-05 | 201 | 114 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1D TRPM4 CATSPERE HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE LRRC8A ATP1A2 | 2.89e-05 | 523 | 114 | 12 | GO:1902495 |
| GeneOntologyCellularComponent | EMILIN complex | 2.95e-05 | 2 | 114 | 2 | GO:1990971 | |
| GeneOntologyCellularComponent | transporter complex | CACNA1D TRPM4 CATSPERE HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE LRRC8A ATP1A2 | 4.71e-05 | 550 | 114 | 12 | GO:1990351 |
| GeneOntologyCellularComponent | T-tubule | 7.22e-05 | 79 | 114 | 5 | GO:0030315 | |
| GeneOntologyCellularComponent | receptor complex | FLT3 HTR3A HTR3E LY96 EMILIN1 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE LIFR ADRA2A | 7.96e-05 | 581 | 114 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | cell tip | 1.02e-04 | 17 | 114 | 3 | GO:0051286 | |
| GeneOntologyCellularComponent | cell pole | 1.68e-04 | 20 | 114 | 3 | GO:0060187 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 2.26e-04 | 22 | 114 | 3 | GO:0098691 | |
| GeneOntologyCellularComponent | serotonin-activated cation-selective channel complex | 2.92e-04 | 5 | 114 | 2 | GO:1904602 | |
| GeneOntologyCellularComponent | serotonin receptor complex | 2.92e-04 | 5 | 114 | 2 | GO:0098665 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle membrane | 4.36e-04 | 6 | 114 | 2 | GO:0099012 | |
| GeneOntologyCellularComponent | cell body | EZR CACNA1D TRPM4 HTR3A KIF1A ATP13A2 CHRNA3 ADORA1 ADRA2A PTPRF WASHC5 SYT5 ATP1A2 USH2A | 5.33e-04 | 929 | 114 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1D TRPM4 HTR3A KIF1A ATP13A2 CHRNA3 ADORA1 ADRA2A PTPRF WASHC5 SYT5 ATP1A2 USH2A | 6.30e-04 | 835 | 114 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 6.73e-04 | 350 | 114 | 8 | GO:0098802 | |
| GeneOntologyCellularComponent | presynaptic membrane | 8.19e-04 | 277 | 114 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | neuronal dense core vesicle | 9.89e-04 | 36 | 114 | 3 | GO:0098992 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1D TRPM4 HTR3A KIF1A ERO1A ATP13A2 CHRNA3 ADORA1 ADRA2A PTPRF WASHC5 CNTNAP4 HRH1 SYT5 ATP1A2 USH2A | 1.02e-03 | 1228 | 114 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1D CATSPERE HTR3A HTR3E NOX4 EMILIN1 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ATP1A2 | 1.20e-03 | 785 | 114 | 12 | GO:0098797 |
| GeneOntologyCellularComponent | dense core granule membrane | 1.29e-03 | 10 | 114 | 2 | GO:0032127 | |
| GeneOntologyCellularComponent | postsynapse | VHL HTR3A KIF1A HTR3E SLITRK3 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A PTPRF ATP1A2 | 1.29e-03 | 1018 | 114 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | endosome | EZR FLT3 MAGEL2 UBXN6 STEAP4 ATP9B PMEL LY96 ATP13A2 ABCG1 PTPRF WASHC5 TBCK SYT5 ATP1A2 | 1.69e-03 | 1167 | 114 | 15 | GO:0005768 |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.75e-03 | 503 | 114 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | uropod | 2.57e-03 | 14 | 114 | 2 | GO:0001931 | |
| GeneOntologyCellularComponent | cell trailing edge | 2.96e-03 | 15 | 114 | 2 | GO:0031254 | |
| GeneOntologyCellularComponent | dense core granule | 3.55e-03 | 56 | 114 | 3 | GO:0031045 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 3.80e-03 | 17 | 114 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | sarcolemma | 3.89e-03 | 190 | 114 | 5 | GO:0042383 | |
| HumanPheno | Fatigable weakness of neck muscles | 8.11e-05 | 13 | 35 | 3 | HP:0030199 | |
| HumanPheno | Decreased miniature endplate potentials | 8.11e-05 | 13 | 35 | 3 | HP:0003402 | |
| HumanPheno | EMG: impaired neuromuscular transmission | 9.41e-05 | 36 | 35 | 4 | HP:0100285 | |
| HumanPheno | EMG abnormality | 1.14e-04 | 293 | 35 | 9 | HP:0003457 | |
| HumanPheno | Decreased size of nerve terminals | 1.28e-04 | 15 | 35 | 3 | HP:0003443 | |
| HumanPheno | Hip flexor weakness | 1.28e-04 | 15 | 35 | 3 | HP:0012515 | |
| Domain | - | 4.60e-11 | 23 | 110 | 7 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 4.60e-11 | 23 | 110 | 7 | IPR027361 | |
| Domain | Neurotransmitter_ion_chnl_CS | 7.65e-09 | 45 | 110 | 7 | IPR018000 | |
| Domain | Neur_chan_memb | 8.98e-09 | 46 | 110 | 7 | PF02932 | |
| Domain | Neur_chan_LBD | 1.05e-08 | 47 | 110 | 7 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.05e-08 | 47 | 110 | 7 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.05e-08 | 47 | 110 | 7 | IPR006029 | |
| Domain | - | 1.05e-08 | 47 | 110 | 7 | 2.70.170.10 | |
| Domain | Neur_channel | 1.05e-08 | 47 | 110 | 7 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.05e-08 | 47 | 110 | 7 | IPR006202 | |
| Domain | Nicotinic_acetylcholine_rcpt | 2.68e-08 | 16 | 110 | 5 | IPR002394 | |
| Domain | ERM_C_dom | 7.92e-07 | 4 | 110 | 3 | IPR011259 | |
| Domain | ERM | 7.92e-07 | 4 | 110 | 3 | PF00769 | |
| Domain | ERM | 7.92e-07 | 4 | 110 | 3 | IPR011174 | |
| Domain | Moesin_tail | 6.84e-06 | 7 | 110 | 3 | IPR008954 | |
| Domain | EMI | 2.31e-05 | 10 | 110 | 3 | PF07546 | |
| Domain | DUF3657 | 3.44e-05 | 2 | 110 | 2 | IPR022122 | |
| Domain | Alg10 | 3.44e-05 | 2 | 110 | 2 | IPR016900 | |
| Domain | DUF676 | 3.44e-05 | 2 | 110 | 2 | PF05057 | |
| Domain | Ero1 | 3.44e-05 | 2 | 110 | 2 | IPR007266 | |
| Domain | DIE2_ALG10 | 3.44e-05 | 2 | 110 | 2 | PF04922 | |
| Domain | DUF3657 | 3.44e-05 | 2 | 110 | 2 | PF12394 | |
| Domain | DUF676_lipase-like | 3.44e-05 | 2 | 110 | 2 | IPR007751 | |
| Domain | Tob1/2 | 3.44e-05 | 2 | 110 | 2 | IPR015676 | |
| Domain | ERO1 | 3.44e-05 | 2 | 110 | 2 | PF04137 | |
| Domain | BROMODOMAIN_1 | 6.48e-05 | 37 | 110 | 4 | PS00633 | |
| Domain | BROMODOMAIN_2 | 9.75e-05 | 41 | 110 | 4 | PS50014 | |
| Domain | EMI_domain | 1.05e-04 | 16 | 110 | 3 | IPR011489 | |
| Domain | BROMO | 1.07e-04 | 42 | 110 | 4 | SM00297 | |
| Domain | Bromodomain | 1.07e-04 | 42 | 110 | 4 | IPR001487 | |
| Domain | - | 1.07e-04 | 42 | 110 | 4 | 1.20.920.10 | |
| Domain | EMI | 1.27e-04 | 17 | 110 | 3 | PS51041 | |
| Domain | Ez/rad/moesin-like | 2.45e-04 | 21 | 110 | 3 | IPR000798 | |
| Domain | FERM_CS | 3.68e-04 | 24 | 110 | 3 | IPR019747 | |
| Domain | FERM_C | 4.68e-04 | 26 | 110 | 3 | PF09380 | |
| Domain | Bromodomain_CS | 4.68e-04 | 26 | 110 | 3 | IPR018359 | |
| Domain | BTG_2 | 5.08e-04 | 6 | 110 | 2 | PS01203 | |
| Domain | BTG_1 | 5.08e-04 | 6 | 110 | 2 | PS00960 | |
| Domain | Anti_prolifrtn | 5.08e-04 | 6 | 110 | 2 | IPR002087 | |
| Domain | btg1 | 5.08e-04 | 6 | 110 | 2 | SM00099 | |
| Domain | BTG | 5.08e-04 | 6 | 110 | 2 | PF07742 | |
| Domain | FERM_C | 5.25e-04 | 27 | 110 | 3 | SM01196 | |
| Domain | FERM_PH-like_C | 5.25e-04 | 27 | 110 | 3 | IPR018980 | |
| Domain | - | 8.71e-04 | 32 | 110 | 3 | 3.40.1110.10 | |
| Domain | - | 8.71e-04 | 32 | 110 | 3 | 2.70.150.10 | |
| Domain | FERM_N | 9.54e-04 | 33 | 110 | 3 | PF09379 | |
| Domain | FERM_N | 9.54e-04 | 33 | 110 | 3 | IPR018979 | |
| Domain | ATPase_P-typ_cyto_domN | 1.13e-03 | 35 | 110 | 3 | IPR023299 | |
| Domain | P_typ_ATPase | 1.23e-03 | 36 | 110 | 3 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 1.23e-03 | 36 | 110 | 3 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 1.23e-03 | 36 | 110 | 3 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.33e-03 | 37 | 110 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.33e-03 | 37 | 110 | 3 | PF00122 | |
| Domain | Bromodomain | 1.44e-03 | 38 | 110 | 3 | PF00439 | |
| Domain | Ferric_reduct | 2.18e-03 | 12 | 110 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 2.18e-03 | 12 | 110 | 2 | IPR013130 | |
| Domain | FERM_M | 2.51e-03 | 46 | 110 | 3 | PF00373 | |
| Domain | - | 3.01e-03 | 49 | 110 | 3 | 1.20.80.10 | |
| Domain | FERM_central | 3.01e-03 | 49 | 110 | 3 | IPR019748 | |
| Domain | FERM_domain | 3.01e-03 | 49 | 110 | 3 | IPR000299 | |
| Domain | FERM_1 | 3.19e-03 | 50 | 110 | 3 | PS00660 | |
| Domain | FERM_2 | 3.19e-03 | 50 | 110 | 3 | PS00661 | |
| Domain | FERM_3 | 3.19e-03 | 50 | 110 | 3 | PS50057 | |
| Domain | Band_41_domain | 3.19e-03 | 50 | 110 | 3 | IPR019749 | |
| Domain | B41 | 3.19e-03 | 50 | 110 | 3 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.19e-03 | 50 | 110 | 3 | IPR014352 | |
| Domain | 7TM_GPCR_Srsx | 4.34e-03 | 112 | 110 | 4 | SM01381 | |
| Domain | Cation_ATPase_N | 4.95e-03 | 18 | 110 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.51e-03 | 19 | 110 | 2 | IPR004014 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 4.67e-08 | 7 | 87 | 4 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 4.67e-08 | 7 | 87 | 4 | MM15311 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 6.45e-07 | 12 | 87 | 4 | M48008 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.29e-06 | 14 | 87 | 4 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.75e-06 | 15 | 87 | 4 | MM14704 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 4.47e-05 | 272 | 87 | 9 | M13380 | |
| Pathway | WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY | 4.80e-05 | 12 | 87 | 3 | M45558 | |
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 1.11e-09 | 15 | 116 | 5 | 8838678 | |
| Pubmed | 1.60e-09 | 16 | 116 | 5 | 19259974 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 8479753 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 18261459 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 21659656 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 19064715 | ||
| Pubmed | Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM. | 3.62e-08 | 3 | 116 | 3 | 31843195 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 21864676 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 14613898 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 21278069 | ||
| Pubmed | Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin. | 3.62e-08 | 3 | 116 | 3 | 26555866 | |
| Pubmed | Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. | 3.62e-08 | 3 | 116 | 3 | 23703860 | |
| Pubmed | Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. | 3.62e-08 | 3 | 116 | 3 | 16889625 | |
| Pubmed | Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. | 3.62e-08 | 3 | 116 | 3 | 15149851 | |
| Pubmed | Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells. | 3.62e-08 | 3 | 116 | 3 | 21837648 | |
| Pubmed | ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. | 3.62e-08 | 3 | 116 | 3 | 21352885 | |
| Pubmed | Ezrin and moesin function together to promote T cell activation. | 3.62e-08 | 3 | 116 | 3 | 19124745 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 1429901 | ||
| Pubmed | ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion. | 3.62e-08 | 3 | 116 | 3 | 32098334 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 18295815 | ||
| Pubmed | Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis. | 3.62e-08 | 3 | 116 | 3 | 12360288 | |
| Pubmed | Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. | 3.62e-08 | 3 | 116 | 3 | 22132106 | |
| Pubmed | Dynamics and function of ERM proteins during cytokinesis in human cells. | 3.62e-08 | 3 | 116 | 3 | 28889652 | |
| Pubmed | Control of adipogenesis by ezrin, radixin and moesin-dependent biomechanics remodeling. | 3.62e-08 | 3 | 116 | 3 | 23116763 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 21451358 | ||
| Pubmed | Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading. | 3.62e-08 | 3 | 116 | 3 | 19321616 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 29906485 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 20679347 | ||
| Pubmed | Differential expression and distribution of ezrin, radixin and moesin in human natural killer cells. | 3.62e-08 | 3 | 116 | 3 | 12385025 | |
| Pubmed | Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies? | 3.62e-08 | 3 | 116 | 3 | 25286001 | |
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 17977945 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 15252013 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 32160548 | ||
| Pubmed | 3.62e-08 | 3 | 116 | 3 | 12734202 | ||
| Pubmed | 1.15e-07 | 14 | 116 | 4 | 19059502 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 23519471 | ||
| Pubmed | Design and control of acetylcholine receptor conformational change. | 1.44e-07 | 4 | 116 | 3 | 21368211 | |
| Pubmed | Acetylcholine receptor assembly: subunit folding and oligomerization occur sequentially. | 1.44e-07 | 4 | 116 | 3 | 8334706 | |
| Pubmed | Functional binding interaction identified between the axonal CAM L1 and members of the ERM family. | 1.44e-07 | 4 | 116 | 3 | 12070130 | |
| Pubmed | CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. | 1.44e-07 | 4 | 116 | 3 | 27793041 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 15096511 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 19422391 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 19890007 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 28302370 | ||
| Pubmed | Ceramides modulate cell-surface acetylcholine receptor levels. | 1.44e-07 | 4 | 116 | 3 | 18023270 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 22685202 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 21289089 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 17237445 | ||
| Pubmed | The ERM proteins interact with the HOPS complex to regulate the maturation of endosomes. | 1.44e-07 | 4 | 116 | 3 | 21148287 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 18941185 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 15178693 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 20660156 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 19129194 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 15818415 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 31018575 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 24760896 | ||
| Pubmed | Proteomic profiling in pancreatic cancer with and without lymph node metastasis. | 1.44e-07 | 4 | 116 | 3 | 19152423 | |
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 8872460 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 15864502 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 4781450 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 19255442 | ||
| Pubmed | 1.44e-07 | 4 | 116 | 3 | 9890997 | ||
| Pubmed | Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. | 1.44e-07 | 4 | 116 | 3 | 20855527 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 21278261 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 22891241 | ||
| Pubmed | The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. | 3.60e-07 | 5 | 116 | 3 | 10806479 | |
| Pubmed | Properties of embryonic and adult muscle acetylcholine receptors transiently expressed in COS cells. | 3.60e-07 | 5 | 116 | 3 | 2383398 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 23019340 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 9464455 | ||
| Pubmed | Activated ERM protein plays a critical role in drug resistance of MOLT4 cells induced by CCL25. | 3.60e-07 | 5 | 116 | 3 | 23326330 | |
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 19830727 | ||
| Pubmed | 3.60e-07 | 5 | 116 | 3 | 25575591 | ||
| Pubmed | A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells. | 3.60e-07 | 5 | 116 | 3 | 23063725 | |
| Pubmed | Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study. | 3.60e-07 | 5 | 116 | 3 | 8987816 | |
| Pubmed | A novel role for BRCA1 in regulating breast cancer cell spreading and motility. | 3.60e-07 | 5 | 116 | 3 | 21282464 | |
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 14996434 | ||
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 17349711 | ||
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 26209696 | ||
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 17515952 | ||
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 23229862 | ||
| Pubmed | 7.18e-07 | 6 | 116 | 3 | 9472040 | ||
| Pubmed | MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression. | 1.25e-06 | 7 | 116 | 3 | 23264465 | |
| Pubmed | Developmental expression and biochemical characterization of Emu family members. | 1.25e-06 | 7 | 116 | 3 | 12221002 | |
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 22496563 | ||
| Pubmed | 1.25e-06 | 7 | 116 | 3 | 22291017 | ||
| Pubmed | 2.00e-06 | 8 | 116 | 3 | 24788249 | ||
| Pubmed | Finding the Unicorn, a New Mouse Model of Midfacial Clefting. | 2.99e-06 | 9 | 116 | 3 | 31940751 | |
| Pubmed | Radixin regulates cell migration and cell-cell adhesion through Rac1. | 2.99e-06 | 9 | 116 | 3 | 22467863 | |
| Pubmed | 4.26e-06 | 10 | 116 | 3 | 20736995 | ||
| Pubmed | Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. | 7.78e-06 | 12 | 116 | 3 | 18579745 | |
| Pubmed | 7.78e-06 | 12 | 116 | 3 | 29361573 | ||
| Pubmed | 7.78e-06 | 12 | 116 | 3 | 20584212 | ||
| Pubmed | Embryo-uterine interaction coordinates mouse embryogenesis during implantation. | 1.01e-05 | 13 | 116 | 3 | 37522872 | |
| Pubmed | A molecular blueprint at the apical surface establishes planar asymmetry in cochlear hair cells. | 1.01e-05 | 13 | 116 | 3 | 24135232 | |
| Pubmed | 1.08e-05 | 41 | 116 | 4 | 8724849 | ||
| Pubmed | Multiple-interactions among EMILIN1 and EMILIN2 N- and C-terminal domains. | 1.10e-05 | 2 | 116 | 2 | 25445627 | |
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 22629406 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 25299115 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 19171937 | ||
| Pubmed | 1.10e-05 | 2 | 116 | 2 | 9213396 | ||
| Interaction | OCA2 interactions | 4.67e-09 | 5 | 113 | 4 | int:OCA2 | |
| Interaction | CNNM1 interactions | 1.54e-05 | 56 | 113 | 5 | int:CNNM1 | |
| Interaction | PHLPP2 interactions | 2.99e-05 | 32 | 113 | 4 | int:PHLPP2 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 4.22e-09 | 16 | 74 | 5 | 173 | |
| GeneFamily | EMI domain containing | 2.28e-06 | 7 | 74 | 3 | 540 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 1.65e-05 | 2 | 74 | 2 | 448 | |
| GeneFamily | 5-hydroxytryptamine receptors, ionotropic | 1.64e-04 | 5 | 74 | 2 | 172 | |
| GeneFamily | BTG/Tob family | 2.45e-04 | 6 | 74 | 2 | 1309 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.12e-03 | 50 | 74 | 3 | 1293 | |
| GeneFamily | Ubiquitin specific peptidases | 1.56e-03 | 56 | 74 | 3 | 366 | |
| GeneFamily | Fibronectin type III domain containing | 4.20e-03 | 160 | 74 | 4 | 555 | |
| GeneFamily | General transcription factors|Xeroderma pigmentosum complementation groups|DNA helicases|ERCC excision repair associated | 4.66e-03 | 25 | 74 | 2 | 565 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-08 | 172 | 113 | 8 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-08 | 172 | 113 | 8 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-07 | 186 | 113 | 7 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.92e-07 | 186 | 113 | 7 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.16e-06 | 133 | 113 | 6 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.92e-06 | 164 | 113 | 6 | 362c16ed7fb37bf16601fd5e059d3f3e2ed692b4 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.07e-06 | 177 | 113 | 6 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-06 | 177 | 113 | 6 | 35d42b07d9c31528bf59199e361bb8a3bfbe3b75 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.68e-06 | 180 | 113 | 6 | cc31d2cd06161300b91b17a67bb432b75f0d719b | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.12e-06 | 182 | 113 | 6 | 94d061b7b5ebbfc564c644bc8b2d52341927145d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 8.57e-06 | 188 | 113 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-06 | 188 | 113 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.10e-06 | 190 | 113 | 6 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 195 | 113 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-05 | 195 | 113 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Dendritic_cells-pDC|Control_saline / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 199 | 113 | 6 | 34b95e27581bb127e0b921e9c068dc094cb86b37 | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Dendritic_cells|Control_saline / Treatment groups by lineage, cell group, cell type | 1.22e-05 | 200 | 113 | 6 | 1559844b3116d41a69081e4ee89e64744a760181 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-05 | 152 | 113 | 5 | 77b319f594d5e4df29034bbf69c7490076f89dd3 | |
| ToppCell | Striatum-Neuronal-Inhibitory|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.03e-05 | 157 | 113 | 5 | c41ff3fe9de7187575114febfe9bd8733366fb8a | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.93e-05 | 168 | 113 | 5 | 4c402a1613fcf0a6e4d9b9d5551812940e91ff32 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.96e-05 | 173 | 113 | 5 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.96e-05 | 173 | 113 | 5 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 174 | 113 | 5 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 8.40e-05 | 175 | 113 | 5 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-05 | 175 | 113 | 5 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-05 | 176 | 113 | 5 | 5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-05 | 176 | 113 | 5 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 8.63e-05 | 176 | 113 | 5 | d6e660df92a3d7dd5732171ee623763faf108476 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.63e-05 | 176 | 113 | 5 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.35e-05 | 179 | 113 | 5 | d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159 | |
| ToppCell | COVID-19_Moderate-B_memory|World / disease group, cell group and cell class | 9.60e-05 | 180 | 113 | 5 | 2f37187b866edb56410c2334b72713f2248dc335 | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.60e-05 | 180 | 113 | 5 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.85e-05 | 181 | 113 | 5 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.01e-04 | 182 | 113 | 5 | ad5c99ec62cdab347d3a03c971d981e3b924020c | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 182 | 113 | 5 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 184 | 113 | 5 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 184 | 113 | 5 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 1.06e-04 | 184 | 113 | 5 | 2817d530863e85dfdcd143b7a3dc5fc58a9cd98b | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 185 | 113 | 5 | ef996f4cdbc3971c6c0460d13df64b075ab22154 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 185 | 113 | 5 | d51342a3979bd728a80e04126059a3fd8a0dbe3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 185 | 113 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | 18-Distal-Epithelial-Epithelial|Distal / Age, Tissue, Lineage and Cell class | 1.09e-04 | 185 | 113 | 5 | d2a266724f3f70f746a78034f308d98f8b7a66e3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 185 | 113 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-04 | 186 | 113 | 5 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.12e-04 | 186 | 113 | 5 | 2fdd0a80ad31cf017aafcf5dcf760ebd786b98c1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 188 | 113 | 5 | c2101ded71fb16b8ddbc1f883911b1ed2a533ffc | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 188 | 113 | 5 | 3b8b9161f0fdcbde302ce5b4c0bc874628211109 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-04 | 188 | 113 | 5 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.21e-04 | 189 | 113 | 5 | de06ef69f3f97b3f21dc269eb6965da9b2f6e3f8 | |
| ToppCell | remission-B_memory|World / disease stage, cell group and cell class | 1.24e-04 | 190 | 113 | 5 | c3f55f752e47b5a71e111367cdbed4a39ab5cb21 | |
| ToppCell | wk_08-11-Epithelial-PNS-SST+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.27e-04 | 191 | 113 | 5 | df2bef74a54f4c23c99bd3b93225fd36bcd90723 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 113 | 5 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 113 | 5 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 191 | 113 | 5 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-04 | 101 | 113 | 4 | 6523c314166dcf66c3ed13c02ca4b886b068e5b8 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 192 | 113 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.30e-04 | 192 | 113 | 5 | 75ce635d669ff77d1fd54e10467f21d5e5d67b08 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_mem-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.30e-04 | 192 | 113 | 5 | 80a71ab3434076803466ccac0df73468889c7dd3 | |
| ToppCell | mild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.33e-04 | 193 | 113 | 5 | 7e6fe70928a50b0a8f12220e572c07c5670d092e | |
| ToppCell | NS-moderate-d_0-4-Myeloid-Resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.33e-04 | 193 | 113 | 5 | e530d4349b257f2590c799bf082ed6318700c526 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.33e-04 | 193 | 113 | 5 | 9f798a1bbd9f076c3122d02ed28418c18bb7a369 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.40e-04 | 195 | 113 | 5 | 580ed65b4152483b642a7e7dbdf00d03588c46f6 | |
| ToppCell | severe-Classical_Monocyte|World / disease stage, cell group and cell class | 1.40e-04 | 195 | 113 | 5 | cf638aac4d57ae0774008920a1a5e9dfd8c73885 | |
| ToppCell | mild-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.43e-04 | 196 | 113 | 5 | ded44b38ea489946e9eedfe752b5a9fde9149c16 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 196 | 113 | 5 | 36b4f08fc038dfde6343ff0869e1a027d882adb5 | |
| ToppCell | mild-Myeloid-Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.43e-04 | 196 | 113 | 5 | e9f30eb8a3915c3b2af009c832bff9b349b65ae5 | |
| ToppCell | 3'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 198 | 113 | 5 | f7c89588bc84415acf7488cfb7a86781cd998c69 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.53e-04 | 199 | 113 | 5 | 8c2ab13b5fffbab3da37041a7000d6537fc4db09 | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 1.53e-04 | 199 | 113 | 5 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-04 | 199 | 113 | 5 | 5caaf66b6cddcc8f0d0aee3c9ba80d02075e87e5 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-04 | 199 | 113 | 5 | 7f5d47e49776114d9f4a42017fead9eeb415a94c | |
| ToppCell | Tracheal-NucSeq-Stromal-Schwann-Schwann_Myelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.53e-04 | 199 | 113 | 5 | 4e4bdcd2e8b518156d5ebd294804180acaa3566b | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.57e-04 | 200 | 113 | 5 | 1592ca96c59eb053d0f0915afb337db9f3a40c91 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.57e-04 | 200 | 113 | 5 | 99eb02f974ddc8d1882f4a5b34d4503d6ec0a5f5 | |
| ToppCell | Control-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.81e-04 | 124 | 113 | 4 | 3e987915026f503e8d072a837b6e7a34252e5c63 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.07e-04 | 127 | 113 | 4 | 508b188ccbe5aa6ec0128c443aedb5a8ea35a6d0 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-pDC|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.26e-04 | 129 | 113 | 4 | 454bae525f6db3d0dd6347d2a2c3ea9dda9cd212 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.46e-04 | 131 | 113 | 4 | 1823cab28fab40486247ca92104267b1e370bdc1 | |
| ToppCell | Control-B_memory-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.98e-04 | 136 | 113 | 4 | 94f23bef50c0beb54ed39b1a4b340f7aec4e75cd | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.45e-04 | 140 | 113 | 4 | c3331cb7720f93af8bab35d02c6cbe87dd324d91 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-04 | 140 | 113 | 4 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 4.45e-04 | 140 | 113 | 4 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-04 | 141 | 113 | 4 | 31e0984f09983e83a814424f74c871c1c5a3a789 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.57e-04 | 141 | 113 | 4 | d7d3c3932651d90fa4f3c4e3df16f4b677faaf9f | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.94e-04 | 144 | 113 | 4 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.94e-04 | 144 | 113 | 4 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | TCGA-Peripheral_Nervous_System|World / Sample_Type by Project: Shred V9 | 4.94e-04 | 144 | 113 | 4 | 3bbadb4b07ffb461d5400a5d69ad3b259f74041e | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.48e-04 | 148 | 113 | 4 | 31a7c2b20970070b14d2b955020320a6f99db547 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-04 | 152 | 113 | 4 | 27718e92715ddc80f28b457a5d6d6a3ac2b205d2 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.06e-04 | 152 | 113 | 4 | 0c6dd41142e4ca1e54ca41e05e42ed29fbf0e570 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-04 | 152 | 113 | 4 | b61d2f6ee819c8dd4b4b601a8bc8388b1983de58 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-04 | 154 | 113 | 4 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-04 | 154 | 113 | 4 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | Adult-Immune-dendritic_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.36e-04 | 154 | 113 | 4 | 64a4686586d08b1e9632dde917b472ac660de2d3 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|Heart / Disease (COVID-19 only), tissue and cell type | 6.52e-04 | 155 | 113 | 4 | d7e26696fd9c0a759524f331243db43059b33ed9 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.68e-04 | 156 | 113 | 4 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-LMPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.68e-04 | 156 | 113 | 4 | 331b63bf4744ab494c3959436a8a0d8a1e4c0de4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.84e-04 | 157 | 113 | 4 | a98d06cef80bfe8481b0940abce2b29675e45812 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.84e-04 | 157 | 113 | 4 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| Computational | Genes in the cancer module 267. | 2.97e-06 | 15 | 76 | 4 | MODULE_267 | |
| Computational | Vesicular transport / synapse genes. | 2.34e-05 | 82 | 76 | 6 | MODULE_274 | |
| Computational | Ion channels. | 3.58e-05 | 27 | 76 | 4 | MODULE_214 | |
| Computational | Genes in the cancer module 27. | FLT3 HTR3A CHRNA3 CHRNB1 CHRNB2 CHRNE ADORA1 LIFR ADRA2A PTPRF HRH1 | 3.65e-05 | 355 | 76 | 11 | MODULE_27 |
| Drug | phentolamine | VHL HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A HRH1 ATP1A2 | 3.45e-10 | 200 | 113 | 12 | CID000005775 |
| Drug | metoclopramide | 9.13e-09 | 84 | 113 | 8 | CID000004168 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 4.02e-08 | 20 | 113 | 5 | CID000001962 | |
| Drug | AR-R17779 | 6.78e-08 | 22 | 113 | 5 | CID005310971 | |
| Drug | gallamin | 6.86e-08 | 43 | 113 | 6 | CID000067425 | |
| Drug | alpha-conotoxin ImI | 8.63e-08 | 23 | 113 | 5 | CID000133011 | |
| Drug | ABT-418 | 8.63e-08 | 23 | 113 | 5 | CID000119380 | |
| Drug | Skpymrfamide | 8.63e-08 | 23 | 113 | 5 | CID000132661 | |
| Drug | ipratropium bromide | 1.04e-07 | 46 | 113 | 6 | CID000003746 | |
| Drug | procyclidine | 1.09e-07 | 24 | 113 | 5 | CID000004919 | |
| Drug | anabaseine | 1.09e-07 | 24 | 113 | 5 | CID000018985 | |
| Drug | benzquinamide | 1.67e-07 | 26 | 113 | 5 | CID000002342 | |
| Drug | beta-eudesmol | 1.67e-07 | 26 | 113 | 5 | CID000091457 | |
| Drug | curarine | 1.67e-07 | 26 | 113 | 5 | CID000198004 | |
| Drug | bifemelane | 2.97e-07 | 29 | 113 | 5 | CID000002377 | |
| Drug | amsonine | 3.05e-07 | 181 | 113 | 9 | CID000002866 | |
| Drug | NSC624746 | 3.86e-07 | 57 | 113 | 6 | CID000107640 | |
| Drug | tetrahydrodeoxycortisol | 4.22e-07 | 31 | 113 | 5 | CID000010593 | |
| Drug | dimethylphenylpiperazinium | 4.75e-07 | 59 | 113 | 6 | CID000001316 | |
| Drug | tropicamide | 4.98e-07 | 32 | 113 | 5 | CID000005593 | |
| Drug | hexamethonium | 5.84e-07 | 143 | 113 | 8 | CID000003604 | |
| Drug | decamethonium | 5.85e-07 | 33 | 113 | 5 | CID000002968 | |
| Drug | cytisine | 5.85e-07 | 33 | 113 | 5 | CID000010235 | |
| Drug | GTS-21 | 6.83e-07 | 34 | 113 | 5 | CID005310985 | |
| Drug | (-)-pictamine | 7.53e-07 | 15 | 113 | 4 | CID006918623 | |
| Drug | (-)-lepadin B | 7.53e-07 | 15 | 113 | 4 | CID006918624 | |
| Drug | UB-165 | 7.53e-07 | 15 | 113 | 4 | CID004694339 | |
| Drug | Ultracet | 7.75e-07 | 64 | 113 | 6 | CID000005523 | |
| Drug | (+/-)-Epibatidine | 7.94e-07 | 35 | 113 | 5 | CID000001204 | |
| Drug | EPTC | 7.94e-07 | 35 | 113 | 5 | CID000012968 | |
| Drug | benzilate | 9.32e-07 | 66 | 113 | 6 | CID000201538 | |
| Drug | AC1L2SVN | 1.00e-06 | 16 | 113 | 4 | CID000127922 | |
| Drug | AC1NSKJI | 1.11e-06 | 68 | 113 | 6 | CID005311391 | |
| Drug | clozapine | HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADRA2A HRH1 SYT5 | 1.13e-06 | 274 | 113 | 10 | CID000002818 |
| Drug | NSC-293162 | 1.21e-06 | 38 | 113 | 5 | CID000004675 | |
| Drug | atropine sulfate | HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A HRH1 CCL16 | 1.28e-06 | 347 | 113 | 11 | CID000003661 |
| Drug | tetradotoxin | CACNA1D HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A HRH1 ATP1A2 | 1.49e-06 | 428 | 113 | 12 | CID000020382 |
| Drug | Tubocurarine,d | 1.56e-06 | 72 | 113 | 6 | CID000001210 | |
| Drug | ABT-594 | 1.67e-06 | 18 | 113 | 4 | CID003075702 | |
| Drug | AC1LCVGE | 1.67e-06 | 18 | 113 | 4 | CID000656712 | |
| Drug | NSC755875 | 1.72e-06 | 165 | 113 | 8 | CID000002215 | |
| Drug | phenoxybenzamine | 1.73e-06 | 115 | 113 | 7 | CID000004768 | |
| Drug | NSC100058 | 1.84e-06 | 74 | 113 | 6 | CID000003449 | |
| Drug | acetylcholine | HTR3A NOX4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A HRH1 ATP1A2 | 1.88e-06 | 361 | 113 | 11 | CID000000187 |
| Drug | N-methylscopolamine | 2.02e-06 | 42 | 113 | 5 | CID000004120 | |
| Drug | QX-222 | 2.02e-06 | 42 | 113 | 5 | CID000005014 | |
| Drug | thioperamide | 2.02e-06 | 42 | 113 | 5 | CID003035905 | |
| Drug | AC1L9P88 | 2.10e-06 | 19 | 113 | 4 | CID000450860 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 2.10e-06 | 19 | 113 | 4 | CID000162425 | |
| Drug | isoarecolone | 2.10e-06 | 19 | 113 | 4 | CID000146970 | |
| Drug | beta-erythroidine | 2.10e-06 | 19 | 113 | 4 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 2.10e-06 | 19 | 113 | 4 | CID000107881 | |
| Drug | Nicorette | CACNA1D HTR3A MMP28 HTR3E STEAP4 CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 LIFR CCL16 | 2.29e-06 | 529 | 113 | 13 | CID000000942 |
| Drug | Mirtazapine | 2.36e-06 | 6 | 113 | 3 | DB00370 | |
| Drug | MDMA | 2.44e-06 | 121 | 113 | 7 | CID000001615 | |
| Drug | hemicholinium-3 | 2.51e-06 | 78 | 113 | 6 | CID000003585 | |
| Drug | dihydro-beta-erythroidine | 2.56e-06 | 44 | 113 | 5 | CID000031762 | |
| Drug | ICI 169,369 | 2.62e-06 | 20 | 113 | 4 | CID000122265 | |
| Drug | AC1L1BQX | 2.71e-06 | 79 | 113 | 6 | CID000001565 | |
| Drug | bupropion | 3.13e-06 | 81 | 113 | 6 | CID000000444 | |
| Drug | pilsicainide | 3.21e-06 | 46 | 113 | 5 | CID000004820 | |
| Drug | dinotefuran | 3.23e-06 | 21 | 113 | 4 | CID000197701 | |
| Drug | meproadifen | 3.23e-06 | 21 | 113 | 4 | CID000189752 | |
| Drug | histrionicotoxin | 3.93e-06 | 22 | 113 | 4 | CID005282247 | |
| Drug | clothianidin | 3.93e-06 | 22 | 113 | 4 | CID000213027 | |
| Drug | edrophonium | 3.98e-06 | 48 | 113 | 5 | CID000003202 | |
| Drug | Atracurium | 4.11e-06 | 7 | 113 | 3 | ctd:D001279 | |
| Drug | mivacurium | 4.11e-06 | 7 | 113 | 3 | ctd:C049430 | |
| Drug | brimonidine | 4.45e-06 | 86 | 113 | 6 | CID000002435 | |
| Drug | AC1L3BL8 | 4.74e-06 | 23 | 113 | 4 | CID000086457 | |
| Drug | alpha-conotoxin SI | 4.74e-06 | 23 | 113 | 4 | CID000163979 | |
| Drug | CID6325740 | 4.74e-06 | 23 | 113 | 4 | CID006325740 | |
| Drug | neostigmine | 4.76e-06 | 87 | 113 | 6 | CID000004456 | |
| Drug | McN-A-343 | 4.88e-06 | 50 | 113 | 5 | CID000004022 | |
| Drug | intruder | 5.66e-06 | 24 | 113 | 4 | CID000213021 | |
| Drug | bethanechol | 5.80e-06 | 90 | 113 | 6 | CID000002370 | |
| Drug | anabasine | 6.71e-06 | 25 | 113 | 4 | CID000002181 | |
| Drug | varenicline | 6.71e-06 | 25 | 113 | 4 | CID000170361 | |
| Drug | pempidine | 6.71e-06 | 25 | 113 | 4 | CID000006603 | |
| Drug | Leucomisine [17946-87-1]; Up 200; 16.2uM; HL60; HT_HG-U133A | 6.91e-06 | 199 | 113 | 8 | 6125_UP | |
| Drug | muscarine | 7.72e-06 | 144 | 113 | 7 | CID000009308 | |
| Drug | nefiracetam | 8.60e-06 | 56 | 113 | 5 | CID000071157 | |
| Drug | methylcarbamylcholine | 9.24e-06 | 27 | 113 | 4 | CID000004136 | |
| Drug | nornicotine | 9.24e-06 | 27 | 113 | 4 | CID000000412 | |
| Drug | pozanicline | 9.78e-06 | 9 | 113 | 3 | ctd:C108326 | |
| Drug | EN-1530 | 1.05e-05 | 278 | 113 | 9 | CID000004425 | |
| Drug | propranolol | CACNA1D HTR3A HTR3E CHRNA3 CHRNB1 CHRNB2 CHRND CHRNE ADORA1 ADRA2A HRH1 | 1.08e-05 | 434 | 113 | 11 | CID000004946 |
| Drug | procaine | 1.15e-05 | 153 | 113 | 7 | CID000004914 | |
| Drug | bromoacetylcholine bromide | 1.24e-05 | 29 | 113 | 4 | CID000204966 | |
| Drug | otenzepad | 1.31e-05 | 61 | 113 | 5 | CID000107867 | |
| Drug | methoctramine | 1.54e-05 | 63 | 113 | 5 | CID000004108 | |
| Drug | AC1L1JK6 | 1.63e-05 | 31 | 113 | 4 | CID000005077 | |
| Drug | oxotremorine | 1.66e-05 | 108 | 113 | 6 | CID000004630 | |
| Drug | succinylcholine | 1.66e-05 | 64 | 113 | 5 | CID000005314 | |
| Drug | fluoxetine | 1.69e-05 | 225 | 113 | 8 | CID000003386 | |
| Drug | 4-DAMP | 1.79e-05 | 65 | 113 | 5 | CID000001734 | |
| Drug | cytisine | 1.91e-05 | 11 | 113 | 3 | ctd:C004712 | |
| Drug | rocuronium | 1.91e-05 | 11 | 113 | 3 | ctd:C061870 | |
| Drug | disopyramide | 1.93e-05 | 66 | 113 | 5 | CID000003114 | |
| Drug | methamidophos | 2.11e-05 | 33 | 113 | 4 | CID000004096 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.72e-11 | 16 | 109 | 6 | DOID:3635 (implicated_via_orthology) | |
| Disease | MYASTHENIC SYNDROME, CONGENITAL, 1A, SLOW-CHANNEL | 1.96e-07 | 4 | 109 | 3 | C4084823 | |
| Disease | Long Qt Syndrome 2 | 4.05e-05 | 3 | 109 | 2 | C3150943 | |
| Disease | Myasthenic Syndrome, Congenital, Fast-Channel | 4.05e-05 | 3 | 109 | 2 | C1837122 | |
| Disease | Myasthenic Syndrome, Congenital, with Facial Dysmorphism, associated with Acetylcholine Receptor Deficiency | 8.07e-05 | 4 | 109 | 2 | C1837092 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 8.88e-05 | 195 | 109 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 2.01e-04 | 6 | 109 | 2 | DOID:0050563 (implicated_via_orthology) | |
| Disease | osteoarthritis, hand | 3.48e-04 | 37 | 109 | 3 | EFO_1000789 | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 4.79e-04 | 9 | 109 | 2 | EFO_0800314 | |
| Disease | nervous system disease (implicated_via_orthology) | 8.71e-04 | 12 | 109 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 16 measurement | 8.71e-04 | 12 | 109 | 2 | EFO_0008044 | |
| Disease | Ck-beta-8-1 measurement | 8.71e-04 | 12 | 109 | 2 | EFO_0008085 | |
| Disease | Hypotension | 1.00e-03 | 53 | 109 | 3 | C0020649 | |
| Disease | Cakut | 1.03e-03 | 13 | 109 | 2 | C1968949 | |
| Disease | Withdrawal Symptoms | 1.31e-03 | 58 | 109 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.31e-03 | 58 | 109 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.31e-03 | 58 | 109 | 3 | C0038587 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 1.57e-03 | 16 | 109 | 2 | C0751885 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.77e-03 | 17 | 109 | 2 | C0751883 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 2.22e-03 | 19 | 109 | 2 | C0751884 | |
| Disease | Arthrogryposis | 2.71e-03 | 21 | 109 | 2 | C0003886 | |
| Disease | Autistic Disorder | 2.88e-03 | 261 | 109 | 5 | C0004352 | |
| Disease | leptin measurement | 3.39e-03 | 81 | 109 | 3 | EFO_0005000 | |
| Disease | Myasthenic Syndromes, Congenital | 3.54e-03 | 24 | 109 | 2 | C0751882 | |
| Disease | Nerve Degeneration | 3.64e-03 | 83 | 109 | 3 | C0027746 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ITFYLIIRRKPLFYI | 236 | Q07001 | |
| YLNPLILSYVKRKRF | 1456 | Q96N23 | |
| YYEKVLPRRLVVGYR | 41 | O15467 | |
| RIYRRYIYEPLHKPQ | 931 | Q5SY80 | |
| YIRRLPLFYTINLII | 236 | P32297 | |
| SLRLIAYFVLRYKIR | 661 | P45844 | |
| QIVFYVAIRRRPSLY | 236 | A5X5Y0 | |
| IAVDRYLRVKIPLRY | 101 | P30542 | |
| FIPKRIIIIARYYRH | 201 | O14862 | |
| GPRRLKNLYFLYLIE | 296 | Q86YB8 | |
| EMKFYVVIRRRPLFY | 231 | P46098 | |
| VVYYRLQPSIKARFL | 141 | Q9C0A0 | |
| IFYLIIRRKPLFYLV | 236 | P11230 | |
| RVFQRYAILKYLLVP | 361 | Q5I7T1 | |
| YNYLRTHPLLIRRNL | 1841 | Q8TDJ6 | |
| IYSLIIRRKPLFYVI | 231 | Q04844 | |
| NLFRPFVLQRSLYRK | 501 | Q8IWB1 | |
| RLRSRYYVTRKLFVA | 781 | Q92830 | |
| LAKPLYLQYLERALR | 16 | Q9ULG1 | |
| KIPTQLFYCRKLRYL | 676 | Q8IWT6 | |
| DFVFYAPRLRINKRI | 266 | P35241 | |
| KRIRSSQYPLRNEYI | 271 | P0C881 | |
| KRIRSSQYPLRNEYI | 271 | B2RC85 | |
| VAFPVQYKLSRRPLY | 111 | O15552 | |
| RREYKPYFPQILNRT | 226 | Q8N7X4 | |
| FVRQKYLEYRRIPYT | 1161 | Q9UJ55 | |
| FLFNPYLTRKRRIEV | 216 | P13378 | |
| LRRYPIARVFVIIYM | 691 | Q8TBA6 | |
| ALIALRRRYPQIYAS | 621 | Q9ULI0 | |
| VVSCLPLYVLKYLRR | 1121 | O43861 | |
| LIIRSVLTRPRFKYY | 1331 | Q9P2D6 | |
| QVFDLRRILIRYYIK | 1521 | A6NKB5 | |
| PLFRTQLKTLFRSYY | 401 | Q8NBM8 | |
| VTVYNLFYQLPVRRK | 146 | Q9UHC1 | |
| KYTERRQPLYRFITT | 241 | Q969X5 | |
| VRQLYRRISEPINYF | 521 | Q96JB1 | |
| VYYPQVRKALDSILR | 506 | O94915 | |
| VVRYQRRPSDKYRLI | 416 | Q96JB8 | |
| LRRVQYLLLSRPIDY | 1846 | P50748 | |
| DFVFYAPRLRINKRI | 266 | P26038 | |
| ALRTPRKFYYITLLR | 171 | O60243 | |
| RKFYYITLLRDPVSR | 176 | O60243 | |
| AERLYRYIRSNKPVT | 296 | Q9NPH5 | |
| PAKYRRGQVVLYRLS | 541 | Q2VWP7 | |
| LVLVLYYKFQRLRTP | 61 | Q9H1Y3 | |
| YYKFQRLRTPTHLLL | 66 | Q9H1Y3 | |
| RNTLLYTLRRPYFRK | 161 | P36888 | |
| IYSIFILYRNRVPLN | 441 | Q9NQ11 | |
| FIYDEVRKLILRRYP | 996 | P50993 | |
| LTLRRYFQGIRVYLK | 141 | P05000 | |
| KTPSVVYRQRLYELL | 661 | Q86XA9 | |
| GRRRYARKQLVPLLY | 31 | O43323 | |
| KFLRNVRYRYQPLLE | 236 | Q53R41 | |
| EGPRRLKNLYFLYLI | 296 | Q96HE7 | |
| LHIFYIPRRDLKQLY | 61 | Q9Y6Y9 | |
| FLRPRYRVAYKTVTD | 101 | Q9Y6C2 | |
| FRPRYVTRYKTVTQL | 91 | Q9BXX0 | |
| DFVFYAPRLRINKRI | 266 | P15311 | |
| YRSVQQPLRYLKYRT | 126 | P35367 | |
| SVLTRPRFRYYLNKL | 1226 | Q49AJ0 | |
| KLYFPARVCRYIRIV | 376 | Q96Q07 | |
| IIKSYRKYRRERLPI | 61 | Q8NEQ5 | |
| VEYALKARPLRRYIP | 1176 | Q01668 | |
| NLVSYRTLIRPTYRV | 91 | Q96A83 | |
| IYRPIRQRVYSLLLE | 621 | Q96EK7 | |
| SLLLNRVTPYREKIY | 1251 | Q12756 | |
| LDKLNPYTLYTFRIR | 496 | P42702 | |
| RYSAPANLYVRVRRV | 216 | P10586 | |
| PAVQIKIRELYRRRY | 51 | O75928 | |
| VRIYYQYRRVKPVTR | 316 | Q16816 | |
| PLRRLILFKGARYYV | 426 | Q9H239 | |
| RRKEYLRDYIPLNSI | 26 | A1Z1Q3 | |
| RRTILLLYYLLRSPF | 276 | Q9Y5Y5 | |
| CYLAPKRYRILLVTV | 331 | Q92521 | |
| PYVRVYLLPDKRRRY | 146 | O00445 | |
| LYPSKFTVRVALRYI | 141 | O14804 | |
| IIYYILLRNGIERFR | 3531 | O75445 | |
| RRFLKSRFYLDLVNP | 166 | P49798 | |
| FLIIRTRQGYYIREL | 781 | Q8IZX4 | |
| RLNLRKNYFLYLPVA | 531 | O94933 | |
| VPALYEYTSQLLKRR | 1181 | Q8IZU2 | |
| REYPNLVTIYRSFKR | 91 | Q9HB58 | |
| LVKRQVPLDCVLYRY | 466 | P40967 | |
| STPRLQYYDKVLRLL | 956 | Q12769 | |
| RALQPVKVFRLLYYS | 1101 | P63128 | |
| YDFIIRRKPLFYTIN | 226 | P17787 | |
| YYRALKTRNVPVRLL | 686 | P13798 | |
| YVRIYQIAKRRTRVP | 231 | P08913 | |
| RVFQRYETVKYLLVP | 361 | Q5BKT4 | |
| RKSRRYYPTRLAINL | 276 | Q92759 | |
| LLEPQVRRYIIYNSR | 86 | Q5VZI3 | |
| IYSIPRYVRDLKIQI | 421 | P56180 | |
| LRKYNYTLLRVRLPD | 331 | Q9BZV1 | |
| LLFLEDYVRYTKLPR | 1126 | Q12768 | |
| SYLLRPVQRVAKYAL | 931 | Q96PX9 | |
| YFLYGKTRSRIPLVR | 231 | A6NNV3 | |
| YFLYGKTRSRIPLVR | 271 | P0DV79 | |
| TVRKRNFPFYITYIR | 551 | P10266 | |
| PLRRVDAYRIYLAIF | 201 | Q8NE00 | |
| YTKLSYRVVFPLELR | 271 | O75317 | |
| KPENYRRLDIVRSLY | 171 | P40337 | |
| IYAPLYLIAAILRKR | 41 | Q86UB9 | |
| VYLQRFRPQDYQRLL | 196 | Q9BU02 | |
| AILQLYRGTKYRRFP | 266 | Q687X5 | |
| RIILFDRLLKAYPYK | 441 | Q8TEA7 | |
| AFLQYRRLRKGYTPL | 491 | P40126 | |
| FIISYLYNKLPRRRV | 11 | P50616 | |
| RYTKLSYRVVFPLEL | 266 | P62068 | |
| IRNYVLNYLATRPKL | 86 | Q9UIA9 | |
| RIYADPTKRLELYFR | 51 | Q9Y5Q8 | |
| VYIFRARLYNFLQKP | 206 | Q8NEE8 | |
| IPFRTYVIRYLCKLS | 266 | Q70CQ2 | |
| ALKPYDLRRRLYVIF | 586 | Q9H0M0 | |
| RRRLKVYEIKYPLIS | 66 | A7MCY6 | |
| FIISYLYNKLPRRRA | 11 | Q14106 | |
| SILRRVFYRPYLQIF | 961 | Q8TD43 | |
| DLRLYVLVSTYRPLR | 196 | O95922 | |
| FVFQKALRSLRRYPL | 41 | Q96NY9 |